Clinical Trial Update: Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating a tumor mRNA vaccine in metastatic melanoma, comparing a fixed combination of targeted antigens against individu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Tumor mRNA vaccine

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Malignant Melanoma | Phase 1, Phase 2 | Status: COMPLETED